CORE--PATHOLOGY

$129,243P01FY2007DKNIH

University Of Chicago, Chicago IL

Investigators

Linked publications & trials

Paper 39340639 Paper 39281877 Paper 38251931 Paper 37823200 Paper 37530089 Paper 37468583 Paper 37468493 Paper 37256909 Paper 36867975 Paper 35976425 Paper 35926776 Paper 35912993 Paper 35133089 Paper 34915736 Paper 34825513 Paper 34321982 Paper 34091721 Paper 34042292 Paper 33765680 Paper 33403824 Paper 33026465 Paper 32900691 Paper 32561654 Paper 32405588 Paper 32149733 Paper 32066273 Paper 31880949 Paper 31863294 Paper 31790303 Paper 31760802 Paper 31017011 Paper 30793930 Paper 30610358 Paper 30066583 Paper 29392338 Paper 29357436 Paper 29279874 Paper 29126251 Paper 28980082 Paper 28822796 Paper 28784428 Paper 28154201 Paper 27913855 Paper 27824271 Paper 27612997 Paper 27549355 Paper 27452364 Paper 27038771 Paper 26956131 Paper 26924944 Paper 26608788 Paper 26555954 Paper 26526044 Paper 26414908 Paper 26376133 Paper 25988516 Paper 25947170 Paper 25656372 Paper 25615853 Paper 25108546 Paper 25096802 Paper 25014576 Paper 24657667 Paper 24478243 Paper 24089413 Paper 23917165 Paper 23881525 Paper 23863465 Paper 23720347 Paper 23438422 Paper 23228113 Paper 23177635 Paper 23159588 Paper 23159272 Paper 22976521 Paper 22698623 Paper 22612388 Paper 22591962 Paper 22358148 Paper 22337820 Paper 22245295 Paper 21952643 Paper 21825103 Paper 21123489 Paper 21063698 Paper 21057942 Paper 20818905 Paper 20818325 Paper 20719342 Paper 20652560 Paper 20632168 Paper 20625890 Paper 20623223 Paper 20428098 Paper 20411383 Paper 20132593 Paper 20035974 Paper 19814580 Paper 19710630 Paper 19640901

Abstract

The Pathology Core has been highly successful in the identification of tissue changes and characterizing sites of mineral deposition as well as crystal type in three different type of human stone patients (common CaOx, intestinal bypass patients for obesity with renal stones and brushite) and the GHS rats. In the renewal, this core will oversee and conduct all morphological analyses for Projects by Lingeman and Evans using 1) light micrscopy with special stains to characterize the histopathological patterns and mineral composition of crystal deposition in our new groups of human stone formers (apatite including RTAs, primary hyperparathyroidism, ileostomy, cystinuria, uric acid stones, bariatric and CaOx with high urine pH (> pH 6.3), 2) light and transmission electron microscopic immunohistochemistry to detect the presence of a select group of known inhibitor proteins of crystal formation (osteopontin, prothombin fragment 1, fetuin-A and bikunin) in the interstitium and at the stone-plaque interface, 3) mu CT imaging to quantitate, localize and characterize mineral type of new sites of crystal deposition in whole kidneys or biopsies samples. 4) mu FTIR and electron diffraction detection techniques to identify specific sites of crystal deposition in human biopsy samples and GHS rat kidneys, 5) RT-PCR techniques to determine the presence of osteoblast-like transcripts in the interstitium of the common CaOx stone formers vs intestinal bypass or bariatric stone formers, 6) determine the mechanisms of crystal particle formation and coalescence in CaOx stone formers by quantitating particle growth/coalescence and performing double labeling, tetracyline studies to determine the rate of crystal formation, 7) provide cortical biopsy samples to Project by Coe for VDR analysis and verification of biopsy location, and 8) to assess the GHS rat for plaque formation. Project by Lingeman will supply biopsy samples from the kidney (cortex to papilla) of predetermined groups of human stone formers. Dr. Willis will perform serum and urinary lithium analyses for Project by Coe.

View original record on NIH RePORTER →